Literature DB >> 515225

The antimicrobial specificity of tryptanthrin.

G Honda, M Tabata, M Tsuda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 515225     DOI： 10.1055/s-0028-1097320

Source DB:  PubMed          Journal:  Planta Med        ISSN： 0032-0943            Impact factor:   3.352


× No keyword cloud information.
  13 in total

1.  Kourokhitin, a potential drug containing two active substances.

Authors:  A M Popov; Yu M Gafurov; T V Moskovkina; A V Kachanov; O N Krivoshapko; S E Petrovicheva; V A Stonik
Journal:  Dokl Biochem Biophys       Date:  2009 May-Jun       Impact factor: 0.788

2.  Low-dose action of tryptanthrin and its derivatives against developing embryos of the sea urchin Strongylocentrotus intermedius.

Authors:  Irina G Agafonova; Taisiya V Moskovkina
Journal:  Environ Monit Assess       Date:  2018-08-07       Impact factor: 2.513

3.  Cytotoxicity and reversal of multidrug resistance by tryptanthrin-derived indoloquinazolines.

Authors:  Sung-tsai Yu; Ji-wang Chern; Tzer-ming Chen; Yi-fan Chiu; Hui-ting Chen; Yen-hui Chen
Journal:  Acta Pharmacol Sin       Date:  2010-02       Impact factor: 6.150

4.  7,9-Dichloro-6H,12H-indolo[2,1-b]quinazoline-6,12-dione.

Authors:  Peter Grundt; Kelsi A Douglas; Bogdana Krivogorsky; Victor N Nemykin
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-05-29

5.  Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors.

Authors:  Igor A Schepetkin; Andrei I Khlebnikov; Andrei S Potapov; Anastasia R Kovrizhina; Vladislava V Matveevskaya; Maxim L Belyanin; Dmitriy N Atochin; Svitlana O Zanoza; Nadiya M Gaidarzhy; Sergiy A Lyakhov; Liliya N Kirpotina; Mark T Quinn
Journal:  Eur J Med Chem       Date:  2018-10-12       Impact factor: 6.514

6.  3-[(2-Chloro-6-methyl-quinolin-3-yl)meth-yl]quinazolin-4(3H)-one.

Authors:  S Mohana Roopan; F Nawaz Khan; Sriramakrishnaswamy Kone; Venkatesha R Hathwar; Mehmet Akkurt
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-06-05

7.  Tryptanthrin inhibits angiogenesis by targeting the VEGFR2-mediated ERK1/2 signalling pathway.

Authors:  Xuemei Liao; Xuelin Zhou; Nai-ki Mak; Kwok-nam Leung
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

8.  The synthetic tryptanthrin analogue suppresses STAT3 signaling and induces caspase dependent apoptosis via ERK up regulation in human leukemia HL-60 cells.

Authors:  Anup S Pathania; Suresh Kumar; Santosh K Guru; Shashi Bhushan; Parduman R Sharma; Sravan K Aithagani; Parvinder P Singh; Ram A Vishwakarma; Ajay Kumar; Fayaz Malik
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

9.  Tryptanthrin Suppresses the Activation of the LPS-Treated BV2 Microglial Cell Line via Nrf2/HO-1 Antioxidant Signaling.

Authors:  Young-Won Kwon; So Yeong Cheon; Sung Yun Park; Juhyun Song; Ju-Hee Lee
Journal:  Front Cell Neurosci       Date:  2017-02-02       Impact factor: 5.505

10.  Design, synthesis and biomedical evaluation of mostotrin, a new water soluble tryptanthrin derivative.

Authors:  Alexander Popov; Anna Klimovich; Olga Styshova; Taisiya Moskovkina; Andrey Shchekotikhin; Natalia Grammatikova; Lyubov Dezhenkova; Dmitry Kaluzhny; Peter Deriabin; Andrey Gerasimenko; Anatoly Udovenko; Valentin Stonik
Journal:  Int J Mol Med       Date:  2020-08-06       Impact factor: 4.101
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.